Revvity Stock Today

RVTY Stock   101.10  3.65  3.48%   

Performance

Mild

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Revvity is trading at 101.10 as of the 12th of February 2026; that is 3.48% down since the beginning of the trading day. The stock's open price was 104.75. Revvity has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat mild performance during the last 90 days. Note, on October 13, 2025, Representative Gilbert Cisneros of US Congress acquired under $15k worth of Revvity's common stock.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
6th of April 1983
Category
Healthcare
Classification
Health Care
Revvity is entity of United States. It is traded as Stock on NYSE exchange. The company has 113.38 M outstanding shares of which 7.06 M shares are at this time shorted by private and institutional investors with about 5.05 trading days to cover. More on Revvity
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Revvity Stock Highlights

ESG Sustainability
Environmental
Governance
Social
President CEOPrahlad Singh
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.260.27
Sufficiently Down
Slightly volatile
Gross Profit Margin0.30.48
Way Down
Pretty Stable
Net Debt2.7 B2.6 B
Sufficiently Up
Slightly volatile
Total Current Liabilities1.4 B1.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total3.8 B3.6 B
Sufficiently Up
Slightly volatile
Total Assets12.8 B12.2 B
Sufficiently Up
Slightly volatile
Total Current Assets1.1 B2.2 B
Way Down
Slightly volatile
Total Cash From Operating Activities610.9 M581.8 M
Sufficiently Up
Slightly volatile
Debt Levels
Revvity utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Revvity's leverage profile, showing how much of Revvity's resources are funded through borrowing.
Liquidity
Revvity currently holds 3.52 B in liabilities. Note, when we think about Revvity's use of debt, we should always consider it together with its cash and equity.

Dividends Paid

33.76 Million
Revvity (RVTY) is traded on New York Stock Exchange in USA and employs 11,000 people. Revvity is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.16 B. Revvity conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 113.38 M outstanding shares of which 7.06 M shares are at this time shorted by private and institutional investors with about 5.05 trading days to cover. Revvity generates positive cash flow from operations, but has no cash available
Check Revvity Probability Of Bankruptcy
Ownership Allocation
Revvity owns a total of 113.38 Million outstanding shares. The majority of Revvity outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Revvity to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Revvity. Please pay attention to any change in the institutional holdings of Revvity as this could imply that something significant has changed or is about to change at the company. Also note that almost fourty-five thousand three hundred fifty invesors are currently shorting Revvity expressing very little confidence in its future performance.
Check Revvity Ownership Details

Revvity Historical Income Statement

At this time, Revvity's Depreciation And Amortization is fairly stable compared to the past year. Cost Of Revenue is likely to rise to about 1.4 B in 2026, whereas Interest Expense is likely to drop slightly above 60.1 M in 2026. View More Fundamentals

Revvity Stock Against Markets

Revvity Corporate Management

Andrew OkunChief VPProfile
Joel GoldbergGeneral AdministrationProfile
Jayashree ThackerSenior OfficerProfile
Madhuri FACMGSenior OfficerProfile
Bryan KippSenior LicensingProfile
Miriame VictorSenior OfficerProfile
Magali FourSenior OfficerProfile

Additional Tools for Revvity Stock Analysis

When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.